News

Cipla, an Indian multinational pharmaceutical and biotechnology company, recently presented a new respiratory inhaler called Synchrobreathe (SB) at the South Africa Thoracic Society (SATS) Annual Conference that took place in Cape Town, South Africa between the 7h and the 10th of August. The company will soon launch the innovative inhaler,…

The ACI Association recently compiled a report on Aquinox Pharmaceuticals Inc. based on the company’s internal reports to make them available to the general public. Aquinox is currently developing AQX-1125, an investigational therapy for COPD, which was recently evaluated in a phase 2 clinical trial called FLAGSHIP. Aquinox announced recently that its FLAGSHIP…

Researchers at Ben-Gurion University of the Negev and Soroka University Medical Center in Israel recently published in the journal CHEST the finding that patients with chronic obstructive pulmonary disease (COPD) who were hospitalized due to exacerbations related to the disease and who did not attend…

Six months after the death of the actor, director, singer, author and photographer Leonard Nimoy, his granddaughter is donating the profits of the store founded by her and her grandfather to support research on chronic obstructive pulmonary disease (COPD). Nimoy, who became best known for playing the role of Spock in…

In a recent study published in the journal CHEST, a team of researchers from Israel found that the risk for hospital readmission is nearly three times higher following a chronic obstructive pulmonary disease (COPD) exacerbation if a follow-up visit to a pulmonologist is skipped. The high frequency…

A study conducted by an international team of researchers recently published in the journal Respiratory Research that the combined therapy based on aclidinium bromide and formoterol fumarate is an effective treatment for chronic obstructive pulmonary disease symptoms and exacerbations in patients with moderate to severe disease. The…

After several successful events covering respiratory disease research and drug development, SMi’s conference on COPD will be held again this year in Central London. Now in its seventh consecutive year, SMi’s COPD conference is scheduled for the 19th and 20th October. Sponsored by Quintiles, a leading biotech CRO, this year’s conference will feature an exclusive post-conference event as…

Health Union recently conducted a nationwide survey of patients diagnosed with chronic obstructive pulmonary disease (COPD) and found many of these individuals did not have adequate knowledge of their condition’s risk factors and diagnosis. This surprising result was linked to significant effects on patients’ quality of life, employment, and ability to…

An international team of researchers recently discovered that a proper lung function development during childhood and adolescence has a major impact on the risk of developing chronic obstructive pulmonary disease (COPD) in the future. The study is entitled “Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease” and…

In a recent study published in the journal Lancet Respiratory Medicine, a team of researchers found that low concentrations of CC16 in serum are associated with reduced lung function in childhood, accelerated lung function decline in adulthood and development of moderate airflow limitation in the general…